loading

Aura Biosciences Inc Borsa (AURA) Ultime notizie

pulisher
Jun 04, 2025

BNP Paribas Financial Markets Invests $50,000 in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

15,427 Shares in Aura Biosciences, Inc. (NASDAQ:AURA) Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Has $704,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Learn to Evaluate (AURA) using the Charts - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Brokers Set Expectations for AURA Q2 Earnings - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 15,951 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 31, 2025
pulisher
May 31, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 31, 2025
pulisher
May 30, 2025

Equities Analysts Offer Predictions for AURA FY2028 Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Aura Biosciences (NASDAQ:AURA) Raised to Buy at HC Wainwright - Defense World

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright sets $22 target for Aura Biosciences stock By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Aura Biosciences (AURA) Receives 'Buy' Rating from HC Wainwright & Co. | AURA Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

H.C. Wainwright sets $22 target for Aura Biosciences stock - Investing.com

May 28, 2025
pulisher
May 28, 2025

Aura Biosciences assumed with a Buy at H.C. Wainwright - TipRanks

May 28, 2025
pulisher
May 28, 2025

AURA: Analyst Initiates Buy Rating with $22 Price Target | AURA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Innovative Precision Oncology and Promising Clinical Results Justify Buy Rating for Aura Biosciences Inc - TipRanks

May 28, 2025
pulisher
May 25, 2025

Aura Biosciences (NASDAQ:AURA) Earns Market Outperform Rating from JMP Securities - Defense World

May 25, 2025
pulisher
May 24, 2025

Northern Trust Corp Has $3.18 Million Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 24, 2025
pulisher
May 23, 2025

JMP maintains $19 target on Aura Biosciences stock after FDA insights - Investing.com Canada

May 23, 2025
pulisher
May 23, 2025

Strategic Positioning and Regulatory Advantage Bolster Aura Biosciences Inc’s Buy Rating - TipRanks

May 23, 2025
pulisher
May 22, 2025

Anthony Gibney Buys 721% More Aura Biosciences Shares - simplywall.st

May 22, 2025
pulisher
May 21, 2025

Long Term Trading Analysis for (AURA) - news.stocktradersdaily.com

May 21, 2025
pulisher
May 20, 2025

Aura Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 20, 2025
pulisher
May 20, 2025

Major Stock Moves: Aura Biosciences Inc Sees Insider Buying Spree! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Promising Developments and Strategic Advancements Propel Aura Biosciences Inc’s Buy Rating - TipRanks

May 19, 2025
pulisher
May 17, 2025

Aura Biosciences Advances in Cancer Therapy Trials - TipRanks

May 17, 2025
pulisher
May 16, 2025

Aura Biosciences Raises $69.9 Million in Public Offering - TipRanks

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences announces public offering; shares down - MSN

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences: Strategic Advancements and Clinical Progress Drive Buy Rating - TipRanks

May 16, 2025
pulisher
May 16, 2025

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval - Endpoints News

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

May 16, 2025
pulisher
May 15, 2025

Aura Biosciences Launches Public Offering Of Common Stock And Warrants - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences announces common stock, warrant offering, no amount given - TipRanks

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Prices $75 Million Offering of Shares, Warrants - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences sets terms for $75 million public offering By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences sets terms for $75 million public offering - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Secures $75M Funding: Major Push for Precision Cancer Treatment Development - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Launches Proposed Public Offering of Shares, Warrants - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences (AURA) Initiates Public Offering with Multiple Financial Managers | AURA Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Appoints New Chief Financial Officer - TipRanks

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Proposed Public Offering Of Common Stock And Warrants - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Enrolls First Patient in Phase 1b/2 Trial of Bel-sar for Non-Muscle-Invasive Bladder Cancer and Strengthens Leadership Team with New Appointment - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Major Cancer Therapy Developer Aura Biosciences Announces Strategic Public Offering with Top Wall Street Banks - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Hits Major Milestone in Bladder Cancer Trial, Reveals Strong Pipeline Progress - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Dimensional Fund Advisors LP Buys 73,062 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 14, 2025
pulisher
May 10, 2025

(AURA) Trading Advice - news.stocktradersdaily.com

May 10, 2025
pulisher
May 09, 2025

Barclays PLC Grows Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 09, 2025
pulisher
May 09, 2025

Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) Price Target at $22.75 - Defense World

May 09, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Buys 5,930 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 08, 2025
pulisher
May 01, 2025

Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire

May 01, 2025
pulisher
May 01, 2025

Clinical-Stage Biotech Aura Biosciences Lines Up 3 Key Investor Conferences: What to Expect - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 37.3% in April - Defense World

May 01, 2025
pulisher
Apr 30, 2025

(AURA) Proactive Strategies - news.stocktradersdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Shares Purchased by JPMorgan Chase & Co. - Defense World

Apr 29, 2025
pulisher
Apr 24, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Position Increased by Geode Capital Management LLC - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com

Apr 23, 2025
$1.15
price up icon 1.30%
$584.68
price up icon 0.75%
$308.75
price up icon 1.19%
$37.33
price up icon 2.30%
$4.68
price down icon 3.35%
$492.00
price up icon 1.78%
Capitalizzazione:     |  Volume (24 ore):